Triple-negative breast cancer (TNBC) (hereafter referred to as AR + TNBC) is an aggressive breast cancer subtype that lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene PGR and breast carcinoma.